Related Experiment Video

Updated: Aug 15, 2026

Slow-release Drug Delivery through Elvax 40W to the Rat Retina: Implications for the Treatment of Chronic Conditions
07:49

Slow-release Drug Delivery through Elvax 40W to the Rat Retina: Implications for the Treatment of Chronic Conditions

Published on: September 17, 2014

Reye's syndrome-aspirin link: a bit stronger

W Check

    JAMA
    |March 19, 1982
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    An Acute Retinal Model for Evaluating Blood Retinal Barrier Breach and Potential Drugs for Treatment09:33

    An Acute Retinal Model for Evaluating Blood Retinal Barrier Breach and Potential Drugs for Treatment

    Published on: September 13, 2016

    Iris Fixation via External Pentagram Suturing05:22

    Iris Fixation via External Pentagram Suturing

    Published on: May 5, 2022

    Related Concept Videos

    Allergic Reactions02:06

    Allergic Reactions

    Overview
    Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

    Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

    Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
    Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...